Single-molecule protein sequencing by iterative isolation and identification of N-terminal amino acids
Award amount
$409,295Program and phase
SBIR · Phase IAward year
2022Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- GLYPHIC BIOTECHNOLOGIES, INC.
- Proposal award date
- 2022-09-02
- Contract end date
- 2023-08-31
- UEI
- F57WT7JZDH19
- Solicitation number
- PAR21-247
- Topic code
- NHGRI
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of Anti-Glycan Antibodies Against Multi-Drug Resistant ESKAPE Wound Pathogens
- Single-molecule protein sequencing by barcoding of N-terminal amino acids
- Single-molecule sequencing of post-translational protein modifications
- Single-molecule protein sequencing by detection and identification of N-terminal amino acids
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform to support clinical variant interpretation through probabilistic assessment of functional evidence
- Innovations to expand and accelerate the commercial impact of DNA modifications
- High-throughput Direct Sequencing and Quantitative Mapping of RNA Modifications using Mass Spectrometry.
- Super-resolution single-molecule sequencing by observing the dynamic hybridization of a repertoire of oligonucleotides to DNA targets
- Exhaustive de novo sequencing of every RNA in a sample by a layer-by-layer mass spectrometry ladder intensity approach.
Research funding history
5 SBIR/STTR records share this UEI (2022–2024). Reported award amounts total $1,817,792. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services, Department of Defense